Literature DB >> 2481558

Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast.

H Hamed1, I S Fentiman, M A Chaudary, R D Rubens.   

Abstract

In a prospective randomized study, patients with pleural effusions secondary to breast carcinoma were randomly allocated to be treated by pleurodesis using either intracavitary talc or bleomycin. For 25 assessable treatments in 22 patients, recurrence of effusion was observed in 5 of 15 (33 per cent) of the bleomycin group compared with none in the talc group. It is concluded that talc is superior to bleomycin in controlling pleural effusions secondary to breast carcinoma, but bleomycin may have a role in patients unfit for general anaesthesia or with extensive disease elsewhere.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481558     DOI: 10.1002/bjs.1800761214

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

1.  BTS guidelines for the management of spontaneous pneumothorax.

Authors:  M Henry; T Arnold; J Harvey
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Palliative iodized talc pleurodesis with instillation via tube thoracostomy.

Authors:  A Türler; M Gawenda; M Walter
Journal:  Support Care Cancer       Date:  1997-01       Impact factor: 3.603

Review 3.  Management of malignant pleural effusions.

Authors:  F Grossi; M C Pennucci; L Tixi; M A Cafferata; A Ardizzoni
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

4.  Immunocytochemical detection of P-glycoprotein in the management of malignant effusions.

Authors:  P Athanassiadou; P Athanassiades; E Petrakakou; C Zerva; M Mavrikakis
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

5.  Talc pleurodesis in malignant pleural effusion: a systematic review and meta-analysis.

Authors:  Eleftherios T Beltsios; Georgios Mavrovounis; Antonis Adamou; Nikolaos Panagiotopoulos
Journal:  Gen Thorac Cardiovasc Surg       Date:  2020-11-22

6.  Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.

Authors:  Carolyn M Dresler; Jemi Olak; James E Herndon; William G Richards; Ernest Scalzetti; Stewart B Fleishman; Kemp H Kernstine; Todd Demmy; David M Jablons; Leslie Kohman; Thomas M Daniel; George B Haasler; David J Sugarbaker
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

Review 7.  Diagnosis and management of malignant pleural effusions: state of the art in 2017.

Authors:  Neeraj R Desai; Hans J Lee
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

8.  Bleomycin in the treatment of 50 cases with malignant pleural effusion.

Authors:  Novin Nikbakhsh; Ali Pourhasan Amiri; Danial Hoseinzadeh
Journal:  Caspian J Intern Med       Date:  2011

9.  Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial.

Authors:  Fabio José Haddad; Riad Naim Younes; Jefferson Luiz Gross; Daniel Deheinzelin
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

Review 10.  Interventions for the management of malignant pleural effusions: a network meta-analysis.

Authors:  Amelia O Clive; Hayley E Jones; Rahul Bhatnagar; Nancy J Preston; Nick Maskell
Journal:  Cochrane Database Syst Rev       Date:  2016-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.